Three Peaks Capital Management LLC trimmed its position in Hill-Rom Holdings, Inc. (NYSE:HRC) by 18.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 44,057 shares of the medical technology company’s stock after selling 9,881 shares during the quarter. Hill-Rom makes up 1.3% of Three Peaks Capital Management LLC’s holdings, making the stock its 26th largest position. Three Peaks Capital Management LLC owned about 0.07% of Hill-Rom worth $5,002,000 at the end of the most recent reporting period.
Several other hedge funds have also recently modified their holdings of the company. AE Wealth Management LLC raised its holdings in shares of Hill-Rom by 65.9% in the 4th quarter. AE Wealth Management LLC now owns 5,872 shares of the medical technology company’s stock valued at $667,000 after purchasing an additional 2,333 shares during the period. Wedge Capital Management L L P NC raised its holdings in shares of Hill-Rom by 0.5% in the 4th quarter. Wedge Capital Management L L P NC now owns 132,634 shares of the medical technology company’s stock valued at $15,058,000 after purchasing an additional 690 shares during the period. Johanson Financial Advisors Inc. raised its holdings in shares of Hill-Rom by 11,744.6% in the 4th quarter. Johanson Financial Advisors Inc. now owns 252,883 shares of the medical technology company’s stock valued at $2,228,000 after purchasing an additional 250,748 shares during the period. First Hawaiian Bank bought a new stake in shares of Hill-Rom in the 4th quarter valued at about $205,000. Finally, BKD Wealth Advisors LLC raised its holdings in shares of Hill-Rom by 3.6% in the 4th quarter. BKD Wealth Advisors LLC now owns 4,390 shares of the medical technology company’s stock valued at $498,000 after purchasing an additional 151 shares during the period. 82.78% of the stock is currently owned by institutional investors.
HRC traded down $0.41 on Friday, reaching $115.93. The company had a trading volume of 40,826 shares, compared to its average volume of 295,427. Hill-Rom Holdings, Inc. has a fifty-two week low of $93.88 and a fifty-two week high of $117.10. The stock has a market cap of $7.77 billion, a P/E ratio of 22.82, a P/E/G ratio of 1.80 and a beta of 0.83. The company’s fifty day moving average is $111.62 and its 200 day moving average is $106.26. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.10 and a current ratio of 1.31.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, November 1st. The medical technology company reported $1.69 EPS for the quarter, beating the Zacks’ consensus estimate of $1.65 by $0.04. Hill-Rom had a net margin of 5.24% and a return on equity of 21.67%. The business had revenue of $782.80 million for the quarter, compared to analyst estimates of $759.14 million. During the same quarter in the prior year, the business earned $1.63 EPS. Hill-Rom’s quarterly revenue was up 3.1% on a year-over-year basis. On average, sell-side analysts expect that Hill-Rom Holdings, Inc. will post 5.53 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 16th were paid a $0.21 dividend. The ex-dividend date was Friday, December 13th. This represents a $0.84 dividend on an annualized basis and a yield of 0.72%. Hill-Rom’s dividend payout ratio (DPR) is currently 16.54%.
Separately, Morgan Stanley raised shares of Hill-Rom from an “equal” rating to an “equal weight” rating and upped their target price for the company from $113.00 to $138.00 in a report on Tuesday, December 17th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $121.40.
In other Hill-Rom news, SVP Andreas G. Frank sold 6,000 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $105.83, for a total transaction of $634,980.00. Following the transaction, the senior vice president now owns 40,004 shares in the company, valued at approximately $4,233,623.32. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Deborah Rasin sold 4,739 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $103.97, for a total transaction of $492,713.83. Following the transaction, the senior vice president now owns 31,001 shares in the company, valued at approximately $3,223,173.97. The disclosure for this sale can be found here. 0.73% of the stock is currently owned by corporate insiders.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Further Reading: Derivative
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.